Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Effects of the tumor microenvironment on therapeutic response

Kevin Litchfield • 9 Sep 2022
ESMO 2022
General

Kevin Litchfield, PhD, University College London, London, UK, discusses how the tumor microenvironment affects therapeutic responses and explains how the balance between immunostimulatory and immunosuppressive cell types plays a role in this. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Kevin Litchfield

1:22
Investigating tumor heterogeneity in the TRACERx study
Kevin Litchfield • 9 Sep 2022
2:10
Immune signatures in the tumor microenvironment
Kevin Litchfield • 9 Sep 2022
2:48
Immunotherapy - from bench to bedside
Kevin Litchfield • 4 Nov 2019

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals